Century Therapeutics (United States)
- Research works
- 61 ▲ 172% vs 2013–17
- Citations
- 981 16.1 per fractional work
- Top-10% rate
- 2.9% record average 16.5%
- Open access
- 39% world 28%
Not ranked overall: Century Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 25.3×. Every wedge is a field page.
Which keywords describe research at Century Therapeutics (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Autoimmunity, Genome Engineering, RNA-Guided and Natural Killer Cells.
- Viral Vectors
- Assembly Planning
- TGF-ß
- Foxp3
- Recombinant Protein
- Immune Regulation
- Cancer
- Immunity
- Induced Pluripotent Stem Cells
- Primary Immunodeficiency
- Glycosylation
- NK Cell Recognition
- Genome Engineering
- Chimeric Antigen Receptor
- Immunotherapy
- Cancer Immunotherapy
- CAR T Cells
- Autoimmunity
- RNA-Guided
- Natural Killer Cells
- Genetic Mutations
- Gene Therapy
- Pluripotent Stem Cells
- Inflammation
- Clinical Trials
- Mammalian Cells
- Stem Cell Regulation
- Innate Immunity
- AAV
- Design for Manufacture
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 30 words, with their numbers
- Cancer Immunotherapy11▲ 218×2 topics
- Immunotherapy10▲ 45×3 topics
- CAR T Cells10▲ 420×1 topic
- Chimeric Antigen Receptor10▲ 420×1 topic
- Autoimmunity3▲ 62×4 topics
- Genome Engineering2▲ 117×1 topic
- RNA-Guided2▲ 117×1 topic
- NK Cell Recognition2▲ 100×1 topic
- Natural Killer Cells2▲ 100×1 topic
- Glycosylation2▲ 50×2 topics
- Genetic Mutations2▲ 12×1 topic
- Primary Immunodeficiency2▲ 176×1 topic
- Gene Therapy2▲ 27×2 topics
- Induced Pluripotent Stem Cells2▲ 192×1 topic
- Pluripotent Stem Cells2▲ 97×1 topic
- Immunity2▲ 12×3 topics
- Inflammation1▲ 2.1×3 topics
- Cancer1▲ 2.7×3 topics
- Clinical Trials1▲ 5.6×1 topic
- Immune Regulation1▲ 33×2 topics
- Mammalian Cells1▲ 154×1 topic
- Recombinant Protein1▲ 154×1 topic
- Stem Cell Regulation1▲ 164×1 topic
- Foxp31▲ 108×1 topic
- Innate Immunity1▲ 11×2 topics
- TGF-ß1▲ 24×1 topic
- AAV1▲ 82×1 topic
- Assembly Planning1▲ 41×1 topic
- Design for Manufacture1▲ 41×1 topic
- Viral Vectors1▲ 82×1 topic
Which research topics does Century Therapeutics (United States) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, CRISPR and Genetic Engineering, Immune Cell Function and Interaction and Immunodeficiency and Autoimmune Disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 10 works
- 2 CRISPR and Genetic Engineering Molecular Biology 2 works
- 3 Immune Cell Function and Interaction Immunology 2 works
- 4 Immunodeficiency and Autoimmune Disorders Immunology 2 works
- 5 Pluripotent Stem Cells Research Molecular Biology 2 works
- 6 Biomedical Ethics and Regulation Physiology 1 works
- 7 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
- 8 T-cell and B-cell Immunology Immunology 1 works
- 9 Virus-based gene therapy research Genetics 1 works
- 10 Manufacturing Process and Optimization Industrial and Manufacturing Engineering 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Century Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 172% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Philadelphia
- University of Pennsylvania
- Temple University
- Drexel University
- Thomas Jefferson University
- Children's Hospital of Philadelphia
- Philadelphia University
- Hospital of the University of Pennsylvania
- Fox Chase Cancer Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.